Beta thalassemia major (BT) is an inherited blood disorder caused by reduced or absent synthesis of the hemoglobin beta chains, associated with profound anemia, jaundice, splenomegaly, expanded bone marrow volume, siderosis and cardiomegaly. Because of repeated blood transfusions, BT patients are subjected to peroxidative tissue injury due to secondary iron overload.

Total antioxidant capacity in Mediterranean β-thalassemic patients

Tsamesidis, Ioannis;Pau, Maria Carmina;Turrini, Francesco;
2017-01-01

Abstract

Beta thalassemia major (BT) is an inherited blood disorder caused by reduced or absent synthesis of the hemoglobin beta chains, associated with profound anemia, jaundice, splenomegaly, expanded bone marrow volume, siderosis and cardiomegaly. Because of repeated blood transfusions, BT patients are subjected to peroxidative tissue injury due to secondary iron overload.
2017
Mediterranean countries; chelation therapies; oxidative stress; total antioxidant capacity; β-thalassemia major; Adult; Antioxidants; Biomarkers; Case-Control Studies; Deferoxamine; Female; Ferritins; Greece; Humans; Iron Chelating Agents; Italy; Male; Middle Aged; beta-Thalassemia; Oxidative Stress
File in questo prodotto:
File Dimensione Formato  
Total antioxidant capacity in Mediterrenean β-thalassemic patients.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 140.09 kB
Formato Adobe PDF
140.09 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/977130
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 17
  • ???jsp.display-item.citation.isi??? ND
social impact